University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)

Phase 2

Completed

Conditions: Cancer of Head and Neck

Interventions: Drug: Erbitux, Paclitaxel & Carboplatin
Radiation: Radiation

First Posted Date: 2006-06-22

Last Posted Date: 2019-08-19

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 43

Registration Number: NCT00343083

Locations: 🇺🇸
University of Maryland & Baltimore VA medical centre, Baltimore, Maryland, United States

Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2006-06-14

Last Posted Date: 2021-05-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 6

Registration Number: NCT00336778

Locations: 🇺🇸
University of Maryland Baltimore, Institute of Human Virology, Baltimore, Maryland, United States
🇺🇸
University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

Terminated

Conditions: Barrett Esophagus
Deglutition Disorders
Neoplasm
Esophageal Neoplasms
GERD

First Posted Date: 2006-05-04

Last Posted Date: 2022-02-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 23

Registration Number: NCT00321958

Locations: 🇺🇸
University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, Maryland, United States

Assessment of Coronary Artery Disease by Hybrid PET/CT

Not Applicable

Terminated

Conditions: Coronary Artery Disease

Interventions: Device: Hybrid PET/CT

First Posted Date: 2006-05-03

Last Posted Date: 2021-06-09

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 30

Registration Number: NCT00320931

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Cognitive Remediation for Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

First Posted Date: 2006-02-22

Last Posted Date: 2021-07-21

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 50

Registration Number: NCT00295048

Locations: 🇺🇸
MOSAIC Community Services, Catonsville, Maryland, United States
🇺🇸
University of Maryland - Walter P. Carter Center, Baltimore, Maryland, United States
🇺🇸
VA Maryland Health Care Systen, Baltimore, Maryland, United States

Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients

Not Applicable

Completed

Conditions: Substance Dependence
Mood Disorders
Schizophrenia

Interventions: Behavioral: Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
Behavioral: Supportive Treatment in Addiction Recovery (STAR)
Behavioral: Critical Time Intervention (CTI)

First Posted Date: 2006-02-22

Last Posted Date: 2022-02-18

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 293

Registration Number: NCT00295139

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
🇺🇸
VA Maryland Health Care System, Baltimore, Maryland, United States
🇺🇸
Health Care for the Homeless, Baltimore, Maryland, United States

and more 1 locations

Alcohol Use Disorders in Schizophrenia

Not Applicable

Completed

Conditions: Alcohol Dependence
Schizophrenia
Mood Disorders
Alcohol Abuse

Interventions: Behavioral: Supportive Treatment in Addiction Recovery (STAR)

First Posted Date: 2006-01-23

Last Posted Date: 2020-04-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 54

Registration Number: NCT00280813

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
🇺🇸
Healthcare for the Homeless, Baltimore, Maryland, United States
🇺🇸
VA Maryland Healthcare System, Baltimore, Maryland, United States

and more 1 locations

Renal Effects of Intrarenal Nesiritide

Phase 4

Terminated

Conditions: Heart Failure, Congestive

Interventions: Drug: nesiritide

First Posted Date: 2005-12-28

Last Posted Date: 2019-12-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 2

Registration Number: NCT00270829

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Not Applicable

Completed

Conditions: Fasciitis, Necrotizing
Severe Necrotizing Skin and Soft Tissue Infections
Fournier's Gangrene

Interventions: Drug: Daptomycin 6mg/kg/day

First Posted Date: 2005-12-05

Last Posted Date: 2022-01-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 25

Registration Number: NCT00261807

Locations: 🇺🇸
R Adams Cowley Shock Trauma Center, U. of Maryland Medical Center, Baltimore, Maryland, United States

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Phase 1

Completed

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Biological: MAGE-A3
Biological: HPV-16 vaccine

First Posted Date: 2005-11-23

Last Posted Date: 2019-10-17

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 17

Registration Number: NCT00257738

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy